Literature DB >> 17064245

Baroreflex activation for the treatment of hypertension: principles and practice.

Domenic A Sica1, Thomas E Lohmeier.   

Abstract

This article reviews the history and current status of an innovative nonpharmacological approach for the treatment of resistant hypertension - chronic electrical activation of the afferent limb of the carotid baroreflex. Recent studies in both normotensive and hypertensive canine models have unambiguously demonstrated sustained and clinically relevant reductions in arterial pressure and sympathetic activity in the course of prolonged baroreflex activation. Clinical trials designed to evaluate the efficacy and safety of this therapy in patients with resistant hypertension are now underway in both Europe and the USA.

Entities:  

Mesh：

Year:  2006        PMID： 17064245     DOI： 10.1586/17434440.3.5.595

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN： 1743-4440            Impact factor:   3.166


  5 in total

1.  [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].

Authors:  M Koziolek; J Beige; M Wallbach; D Zenker; G Henning; M Halbach; N Mader; F Mahfoud; G Schlieper; V Schwenger; M Hausberg; J Börgel; M Lodde; M van der Giet; J Müller-Ehmsen; J Passauer; S Parmentier; S Lüders; B K Krämer; S Büttner; F Limbourg; J Jordan; O Vonend; H-G Predel; H Reuter
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

2.  Mechanisms of blood pressure reduction by prolonged activation of the baroreflex.

Authors:  Radu Iliescu; Thomas E Lohmeier
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

Review 3.  The role of nonpharmacologic device interventions in the management of drug-resistant hypertension.

Authors:  William H Frishman; Daniel Glicklich
Journal:  Curr Atheroscler Rep       Date:  2014-05       Impact factor: 5.113

4.  Carotid baroreceptor stimulation for the treatment of resistant hypertension.

Authors:  Vasilios Papademetriou; Michael Doumas; Charles Faselis; Constantinos Tsioufis; Stella Douma; Eugene Gkaliagkousi; Chrysanthos Zamboulis
Journal:  Int J Hypertens       Date:  2011-05-11       Impact factor: 2.420

Review 5.  Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

Authors:  Thomas Unger; Ludovit Paulis; Domenic A Sica
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.